title: Castration-resistant prostate cancer: where we stand in 2013 and what urologists should know.
authors.forename: Axel
authors.initials: A
authors.lastname: Heidenreich
authors.forename: David
authors.initials: D
authors.lastname: Pfister
authors.forename: Axel
authors.initials: A
authors.lastname: Merseburger
authors.forename: Georg
authors.initials: G
authors.lastname: Bartsch
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003226:Congresses as Topic; D019008:Drug Resistance, Neoplasm; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014572:Urology